Helen X. Chen

13.1k citations
84 papers · 8.9k · 2 hit papers · h-index 37

Impact in

  • Oncology top 0.5%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Lung Cancer Research Studies
    • Cancer, Hypoxia, and Metabolism
    • Cancer Genomics and Diagnostics

Papers in

    • Colorectal Cancer Treatments and Studies 18
    • Cancer Treatment and Pharmacology 12
    • Cancer Immunotherapy and Biomarkers 8
    • Lung Cancer Research Studies 8
    • PI3K/AKT/mTOR signaling in cancer 13
    • Angiogenesis and VEGF in Cancer 11
    • Melanoma and MAPK Pathways 9

Helen X. Chen

81 papers receiving 8.7k citations

Helen X. Chen's Hit Papers

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma 2010 · 1.2k citations
1.2k0+7+15Years since publication50010001.5k2.0k

Peers

Helen X. Chen
Comparison fields: 5 of 136
  • Oncology 4.1k
  • Cancer Research 2.0k
  • Neurology 1.6k
  • Pulmonary and Respiratory Medicine 2.6k
  • Hepatology 476
Replace Emily K. Bergsland with:
Emily K. Bergsland United States
Charles M. Baum United States
Gerald S. Falchook United States
Marcia S. Brose United States
Beow Y. Yeap United States
Michele Reni Italy
Christian Kollmannsberger Canada
David Lebwohl United States
Federica Perrone Italy
Wells A. Messersmith United States
Helen X. Chen relative to Emily K. Bergsland United States Emily K. Bergsland's profile →
Citations per field
00.5×1.5×
Emily K. Bergsland · 1×
Citations per year

Countries citing papers authored by Helen X. Chen

Since Specialization
Citations

This map shows the geographic impact of Helen X. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen X. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen X. Chen more than expected).

Fields of papers citing papers by Helen X. Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen X. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen X. Chen. The network helps show where Helen X. Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Helen X. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Helen X. Chen Line = papers co-authored together Helen X. Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
Hit paper breakdown →
20032100
2
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
Hit paper breakdown →
20101233
3 2009445
4 2009383
5 2007332
6 2008307
7 2010300
8 2006283
9 2008260
10 2008202
11 2020190
12 2010189
13 2013167
14 2012163
15 2006157
16 2011147
17 2012144
18 2013129
19 2004118
20 2007118

About Helen X. Chen

Helen X. Chen is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 84 papers that have together received 8.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (18 papers), PI3K/AKT/mTOR signaling in cancer (13 papers), Cancer Treatment and Pharmacology (12 papers), Angiogenesis and VEGF in Cancer (11 papers), Neuroendocrine Tumor Research Advances (10 papers), Melanoma and MAPK Pathways (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Lung Cancer Research Studies (8 papers). The work is most often cited by research in Oncology (4.1k citations), Cancer Research (2.0k citations), Neurology (1.6k citations), Pulmonary and Respiratory Medicine (2.6k citations) and Hepatology (476 citations). Helen X. Chen has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Seth M. Steinberg, James Chih‐Hsin Yang, Patrick Hwu, Douglas J. Schwartzentruber, Leah Haworth, Steven A. Rosenberg, Richard M. Sherry, Suzanne L. Topalian, Jessica N. Cleck and Janet Dancey. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, The Oncologist and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact